Physician profile
Anne Tenthoff
NPI 1669676797
$8,409.22
in general payments reported to CMS, 2019-2025
43 companies · $567 in 2025
The $567 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,867 · 2020: $1,252 · 2021: $2,185 · 2022: $502 · 2023: $773 · 2024: $1,264 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,603.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,431.25 | 2021-2025 | Qulipta, Vraylar, Ubrelvy |
| Novo Nordisk INC | $1,203.71 | 2019-2025 | Wegovy, Rybelsus |
| Lilly USA, LLC | $922.94 | 2019-2024 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $502.48 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Astellas Pharma US INC | $448.33 | 2019-2025 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $426.38 | 2019-2023 | Steglujan, Belsomra, Steglatro |
| Glaxosmithkline, LLC. | $404.78 | 2019-2025 | Arexvy, Trelegy Ellipta |
| Pfizer INC. | $403.49 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $339.32 | 2019-2022 | |
| Allergan, INC. | $297.93 | 2019-2020 | |
| Abbott Laboratories | $247.92 | 2021-2025 | Freestyle Libre 3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $233.98 | 2019-2020 | |
| Amgen INC. | $147.94 | 2019-2025 | Repatha, Otezla, Repatha |
| Global Blood Therapeutics, INC. | $128.40 | 2020-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $108.53 | 2024-2025 | Caplyta |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Tenthoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.